Arun Sanyal, MD
Enriched profileProfessor of Medicine, Physiology and Molecular Pathology; Director, Stravitz-Sanyal Institute for Liver Disease and Metabolic Health; Interim Chair, Division of Gastroenterology, Hepatology and Nutrition · Virginia Commonwealth University (VCU) School of Medicine
Arun Sanyal is Professor of Medicine, Physiology and Molecular Pathology; Director, Stravitz-Sanyal Institute for Liver Disease and Metabolic Health; Interim Chair, Division of Gastroenterology, Hepatology and Nutrition at Virginia Commonwealth University (VCU) School of Medicine. ClinicalTrials.gov lists 18 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 31 Aug 2026
Arun J. Sanyal, MD, is Professor of Medicine, Physiology and Molecular Pathology at Virginia Commonwealth University (VCU) School of Medicine / VCU Health, Richmond, VA. The public record shows 23 publications with 1,128 citations (h-index 12), centered on NASH / NAFLD / MASH. It also documents an investigator role on 18 registered clinical trials, industry payments reported by 36 companies, 22 NIH-funded awards (1993–2026).
- Top research focus: NASH / NAFLD / MASH
- 18 registered trials on ClinicalTrials.gov
- Open Payments reporting from 36 companies
Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
- Established the Liver Forum to bring FDA
European Medicines Agency, NIH, academia and industry together to accelerate NASH/fibrosis therapeutic development and inform regulatory approach
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academicmedicaleducation.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 31 Aug 2026
Listed as an investigator on 18 registered studies on ClinicalTrials.gov. The most recent:
- Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Sponsor: Foundation for the National Institutes of Health
- Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)
Sponsor: PharmaNest, Inc
- A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis
Sponsor: Galmed Pharmaceuticals Ltd
Industry payments
Updated 31 Aug 2026
36 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20258 payments$12,548openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year20257 payments$11,600openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20252 payments
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Bile Acid100%Ursodiol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 31 Aug 2026
22 NIH research awards on record, funded 1993–2026 per NIH RePORTER. The latest:
- Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis
Virginia Commonwealth University
FY2026$533,999R01DK129564 - Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) - Virginia Commonwealth University
Virginia Commonwealth University
FY2026$341,550U01AA026979
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD
Clinical Gastroenterology and Hepatology
2025 - A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASH
Journal of Hepatology
2025
Online presence
Updated 31 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- X / Twitter
x.com/ArunJSanyalVCU
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/vcu-liver-institute_dr-arun-sanyal-plenary-lecture-the-new-activity-7173360376049291264-YEv6
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 31 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MBBS
Maulana Azad Medical College, Delhi University, India
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - MD
All India Institute of Medical Sciences, New Delhi
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Internal Medicine Residency
Texas Tech University Health Sciences Center, Amarillo, TX
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vcuhealth.org ↗ - Fellowship in Gastroenterology and Hepatology
Virginia Commonwealth University Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vcuhealth.org ↗ - Founding member
Hepatology subspecialty committee, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academicmedicaleducation.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
- Chairman
NIH NASH Clinical Research Network (NASH CRN) Steering Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.vcu.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.vcu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.vcu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vcuhealth.org ↗
Secondary affiliations
appointments beyond the home institution- Education Core Director
C. Kenneth and Dianne Wright Center for Clinical and Translational Research, VCU
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.vcu.edu ↗ - Scientific Advisory Board member
Yale Liver Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academicmedicaleducation.com ↗ - Scientific advisor/board member
NorthSea Therapeutics
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →northseatherapeutics.com ↗
Media & interviews
press, podcasts and appearances- Patients Come First Podcast (Virginia Hospital & Healthcare Association)
interview on liver disease research and philanthropic gift to VCU
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vhha.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →consultant360.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona